SOCIUM Inc
ActiveAI-nativeSOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules.
What it does
SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.
Its site says now · captured 2026-08-23
SOCIUM is a drug discovery venture company with the corporate vision of
Next to it in Healthcare and bio · AI-powered drug discovery and development
- CardiaTec BiosciencesPlug and Play
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
- OwkinPlug and Play
Owkin combines life-science and machine learning expertise to make drug development and clinical trial design more targeted and more cost effective. Owkin's machine learning algorithms create models that predict disease evolution and treatment outcomes.
- RevorfPlug and Play
Revorf is a medical technology and drug discovery platform.
- サスメド株式会社Plug and Play
Sustainable Medicine AI automatic analysis system Development company.
- Numerion LabsY Combinator W15
Artificial intelligence for drug discovery.
- モジュラス株式会社Plug and Play
Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.
- OmniSciencePlug and Play
OmniScience is a leading AI organization advancing life science missions through unparalleled expertise in biology and data science.
- Verge GenomicsY Combinator S15
We use human data and AI to develop better drugs faster.